Sign in
Explore the registryTrack Donanemab's trials

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

DonanemabOngoingActive not recruitingPhase 3Open NCT05738486 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…